14-16 November 2018 – Takis attends NeoAg Summit, Boston
The NeoAg Summit is the annual industry focused meeting dedicated to advancing neoantigen based cancer vaccines and cell therapies. The meeting brings together research groups and companies from all over the world working on neo-antigens, with the aim of exchanging ideas and results to overcome current limitations and accelerate safe, effective and scalable neoantigen-based therapies.
There in Boston, we found an exceptional platform to discuss the promises and challenges of an ever-expanding field of research. This experience has strengthened our determination to pursue the aim of realizing individualised therapeutic vaccines targeting tumor neoantigens in patients. We bet on personalized medicine, as we aware of the enormous benefits that could bring to patients.